Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: A randomized controlled trial

Pediatrics

Volumn 129, Issue 1, 2012, Pages 116-123

  Manzoni, Paolo ^a   Stolfi, Ilaria ^b   Messner, Hubert ^c   Cattani, Silvia ^d   Laforgia, Nicola ^e   Romeo, Mario G ^f   Bollani, Lina ^g   Rinaldi, Matteo ^h   Gallo, Elena ^a   Quercia, Michele ^e   Maule, Milena ⁱ   Mostert, Michael ⁱ   Decembrino, Lidia ^g   Magaldi, Rosario ^h   Mosca, Fabio ^j   Vagnarelli, Federica ^k   Memo, Luigi ^l   Betta, Pasqua M ^f   Stronati, Mauro ^h   Farina, Daniele ^a  

^a S ANNA HOSPITAL   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c Ospedale Regionale   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e POLICLINICO   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^h OSPEDALI RIUNITI   (Italy)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j IRCCS   (Italy)

^k NICU   (Italy)

^l CA FONCELLO HOSPITAL   (Italy)

more..

Author keywords

Candida; Fungal sepsis; Lactoferrin; Prophylaxis; VLBW neonates

Indexed keywords

BOVINE LACTOFERRIN; LACTOFERRIN; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG FATALITY; DRUG HYPERSENSITIVITY; FEMALE; FUNGAL COLONIZATION; HUMAN; INFANT; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOSIS; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VERY LOW BIRTH WEIGHT;

EID: 84855281430     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-0279     Document Type: Article

References (25)

1. Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev. 2004;17(3):638-680 (Pubitemid 38970686)
2. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics. 2001;107(2):293-298 (Pubitemid 32121244)
3. Manzoni P, Farina D, Leonessa ML, et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics. 2006;118(6):2359-2364 (Pubitemid 46397574)
4. Kaufman DA, Manzoni P. Strategies to prevent invasive candidal infection in extremely preterm infants. Clin Perinatol. 2010;37(3):611-628
5. Kaufman DA, Boyle R, Grossman LB, et al. Fluconazole prophylaxis dosing and the resistance patterns in preterm infants over an 11-year period. In: Pediatric Academic Society Annual Meeting; May 1, 2010; Vancouver, Canada. Abstract E-PAS20101370.7
6. Manzoni P, Leonessa M, Galletto P, et al. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr Infect Dis J. 2008;27(8):731-737
7. Orsi N. The antimicrobial activity of lactoferrin: current status and perspectives. Biometals. 2004;17(3):189-196 (Pubitemid 38987136)
8. Ward PP, Uribe-Luna S, Conneely OM. Lactoferrin and host defense. Biochem Cell Biol. 2002;80(1):95-102 (Pubitemid 34194233)
9. Lupetti A, Brouwer CP, Bogaards SJ, et al. Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection. J Infect Dis. 2007;196(9):1416-1424 (Pubitemid 351412016)
10. Manzoni P, Rinaldi M, Cattani S, et al Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low birth weight neonates: a randomized trial. JAMA. 2009;302(13):1421-1428
11. Charles PE, Dalle F, Aube H, et al. Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med. 2005;31(3):393-400
12. Manzoni P, Farina D, Galletto P, et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med. 2007;35(3):220-226 (Pubitemid 46700985)
13. Ascioglu S, Rex JH, de Pauw B, et al Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7-14 (Pubitemid 33152659)
14. Manzoni P, Pedicino R, Stolfi I, et al; Task Force per le infezioni fungine neonatali del GSIN; Socieà Italiana di Neonatologia. Criteria for the diagnosis of systemic fungal infections in newborns: a report from the Task Force on neonatal fungal infections of the GSIN [in Italian]. Pediatr Med Chir. 2004;26(2):89-95
15. National Committee for Clinical Laboratory Standards (NCCLS). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997
16. Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother. 1999;43(11):2635-2641 (Pubitemid 29519541)
17. Lupetti A, Paulusma-Annema A, Welling MM, et al. Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species. Antimicrob Agents Chemother. 2003;47(1):262-267 (Pubitemid 36070373)
18. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345(23):1660-1666 (Pubitemid 33126821)
19. Manzoni P, Stolfi I, Pugni L, et al Italian Task Force for the Study and Prevention of Neonatal Fungal Infections; Italian Society of Neonatology. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. 2007;356(24):2483-2495 (Pubitemid 46919774)
20. Buccigrossi V, de Marco G, Bruzzese E, et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res. 2007;61(4):410-414 (Pubitemid 46569292)
21. Huang YC, Su LH, Wu TL, Lin TY. Genotyping analysis of colonizing candidal isolates from very-low-birth weight infants in a neonatal intensive care unit. J Hosp Infect. 2004;58(3):200-203
22. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis. 2006;42(12):1735-1742 (Pubitemid 43839439)
23. Romeo MG, Romeo DM, Trovato L, et al Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol. 2011;31(1):63-69
24. Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics. 2005;116(2):400-406 (Pubitemid 44161466)
25. Andersson Y, Lindquist S, Lagerqvist C, Hernell O. Lactoferrin is responsible for the fungistatic effect of human milk. Early Hum Dev. 2000;59(2):95-105